Usefulness of Microvolt T-Wave Alternans to Predict Outcomes in Patients With Ischemic Cardiomyopathy Beyond One Year

American Journal of Cardiology

Volumn 102, Issue 3, 2008, Pages 280-284

  Chan, Paul S ^a   Kereiakes, Dean J ^b   Bartone, Cheryl ^b   Chow, Theodore ^b  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^b CHRIST HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CARDIOVASCULAR RISK; COHORT ANALYSIS; DEFIBRILLATOR; DISEASE DURATION; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE ARRHYTHMIA; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MICROVOLT T WAVE ALTERNANS; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; T WAVE AMPLITUDE;

AGED; CARDIOMYOPATHIES; DEFIBRILLATORS, IMPLANTABLE; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MYOCARDIAL ISCHEMIA; REGRESSION ANALYSIS;

EID: 51749123549     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2008.03.049     Document Type: Article

References (16)

1. Bloomfield D.M., Steinman R.C., Namerow P.B., Parides M., Davidenko J., Kaufman E.S., Shinn T., Curtis A., Fontaine J., Holmes D., et al. Microvolt T-wave alternans distinguishes between patients likely and patients not likely to benefit from implanted cardiac defibrillator therapy: a solution to the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II conundrum. Circulation 110 (2004) 1885-1889
2. Hohnloser S.H., Ikeda T., Bloomfield D.M., Dabbous O.H., and Cohen R.J. T-wave alternans negative coronary patients with low ejection and benefit from defibrillator implantation. Lancet 362 (2003) 125-126
3. Chow T., Kereiakes D.J., Bartone C., Booth T., Schloss E.J., Waller T., Chung E., Menon S., Nallamothu B.K., and Chan P.S. Prognostic utility of microvolt T-wave alternans in risk stratifying patients with ischemic cardiomyopathy. J Am Coll Cardiol 47 (2006) 1820-1827
4. Gehi A.K., Stein R.H., Metz L.D., and Gomes J.A. Microvolt T-wave alternans for the risk stratification of ventricular tachyarrhythmic events: a meta-analysis. J Am Coll Cardiol 46 (2005) 75-82
5. Costantini O. The Alternans Before Cardioverter-Defibrillator (ABCD) trial: a noninvasive strategy for primary prevention of sudden cardiac death using T wave alternans. [abstract]. Circulation 114 (2006) 2426
6. Zipes D.P., Camm A.J., Borggrefe M., Buxton A.E., Chaitman B., Fromer M., Gregoratos G., Klein G., Moss A.J., Myerburg R.J., et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). J Am Coll Cardiol 48 (2006) e247-e346
7. Bloomfield D., Hohnloser S., and Cohen R. Interpretation and classification of microvolt T wave alternans tests. J Cardiovasc Electrophysiol 13 (2002) 502-512
8. Chan P.S., Bartone C., Booth T., Kereiakes D., and Chow T. Prognostic implication of redefining indeterminate microvolt T-wave alternans studies as abnormal or normal. Am Heart J 153 (2007) 523-529
9. Kaufman E.S., Bloomfield D.M., Steinman R.C., Namerow P.B., Costantini O., Cohen R.J., and Bigger Jr. J.T. "Indeterminate" microvolt T-wave alternans tests predict high risk of death or sustained ventricular arrhythmias in patients with left ventricular dysfunction. J Am Coll Cardiol 48 (2006) 1399-1404
10. Chan P.S., Nallamothu B.K., and Chow T. Microvolt T-wave alternans: where do we go from here?. [letter to the editor]. J Am Coll Cardiol 47 (2006) 1736
11. Hinkle Jr. L.E., and Thaler H.T. Clinical classification of cardiac deaths. Circulation 65 (1982) 457-464
12. Centers for Disease Control and Prevention. National Death Index User's Manual (2003), Centers for Disease Control and Prevention, Bethesda, Maryland, 5-31
13. Hosmer D., and Lemeshow S. Applied Survival Analysis: Regression Modeling of Time to Event Data (1999), John Wiley, New York 241-270
14. Kleinbaum D. Survival Analysis (1996), Springer-Verlag, New York 211-256
15. Moss A.J., Zareba W., Hall W.J., Klein H., Wilber D.J., Cannom D.S., Daubert J.P., Higgins S.L., Brown M.W., Andrews M.L., and Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346 (2002) 877-883
16. Bardy G.H., Lee K.L., Mark D.B., Poole J.E., Packer D.L., Boineau R., Domanski M., Troutman C., Anderson J., Johnson G., et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352 (2005) 225-237